Evidence-based use of recombinant FVIIa (NovoSeven®,...

Transfusion and Apheresis Science 2008 Vol. 38; Iss. 1

Evidence-based use of recombinant FVIIa (NovoSeven®, NiaStase®) for the treatment of hemophilia with inhibitors in children and adolescents

Brahm Goldstein, Brian Geldziler, Jens Bjerre, Stephanie Seremetis
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
38
Year:
2008
Language:
english
DOI:
10.1016/j.transci.2007.12.002
File:
PDF, 122 KB
english, 2008
Conversion to is in progress
Conversion to is failed